Zentalis Pharmaceuticalsllc Stock Gross Profit
ZNTL Stock | USD 15.19 1.10 7.81% |
Zentalis PharmaceuticalsLlc fundamentals help investors to digest information that contributes to Zentalis PharmaceuticalsL's financial success or failures. It also enables traders to predict the movement of Zentalis Stock. The fundamental analysis module provides a way to measure Zentalis PharmaceuticalsL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zentalis PharmaceuticalsL stock.
Gross Profit is expected to rise to about (1.3 M) this year. Zentalis | Gross Profit |
Zentalis Gross Profit Analysis
Zentalis PharmaceuticalsL's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Zentalis PharmaceuticalsL Gross Profit | (1.3M) |
Most of Zentalis PharmaceuticalsL's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zentalis PharmaceuticalsLlc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Zentalis Gross Profit Driver Correlations
Understanding the fundamental principles of building solid financial models for Zentalis PharmaceuticalsL is extremely important. It helps to project a fair market value of Zentalis Stock properly, considering its historical fundamentals such as Gross Profit. Since Zentalis PharmaceuticalsL's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Zentalis PharmaceuticalsL's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Zentalis PharmaceuticalsL's interrelated accounts and indicators.
Click cells to compare fundamentals
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition |
Zentalis Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zentalis PharmaceuticalsL's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zentalis PharmaceuticalsL could also be used in its relative valuation, which is a method of valuing Zentalis PharmaceuticalsL by comparing valuation metrics of similar companies.Zentalis PharmaceuticalsL is currently under evaluation in gross profit category among related companies.
Zentalis Fundamentals
Return On Equity | -0.67 | ||||
Return On Asset | -0.29 | ||||
Current Valuation | 560.06 M | ||||
Shares Outstanding | 70.96 M | ||||
Shares Owned By Insiders | 4.22 % | ||||
Shares Owned By Institutions | 95.78 % | ||||
Number Of Shares Shorted | 16.74 M | ||||
Price To Book | 2.29 X | ||||
EBITDA | (252.55 M) | ||||
Net Income | (292.19 M) | ||||
Cash And Equivalents | 455.22 M | ||||
Cash Per Share | 7.99 X | ||||
Total Debt | 45.77 M | ||||
Debt To Equity | 0.1 % | ||||
Current Ratio | 9.61 X | ||||
Book Value Per Share | 6.18 X | ||||
Cash Flow From Operations | (207.82 M) | ||||
Short Ratio | 16.80 X | ||||
Earnings Per Share | (4.47) X | ||||
Target Price | 34.4 | ||||
Number Of Employees | 124 | ||||
Beta | 1.72 | ||||
Market Capitalization | 1.01 B | ||||
Total Asset | 562.03 M | ||||
Retained Earnings | (888.56 M) | ||||
Working Capital | 427.35 M | ||||
Z Score | 10.43 | ||||
Net Asset | 562.03 M |
About Zentalis PharmaceuticalsL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zentalis PharmaceuticalsLlc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zentalis PharmaceuticalsL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zentalis PharmaceuticalsLlc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported | Projected for 2024 | ||
Gross Profit | -1.4 M | -1.3 M | |
Gross Profit Margin | 0.00 | 0.00 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.MSFT | Microsoft | |
GOOG | Alphabet Class C | |
S | SentinelOne |
Check out Zentalis PharmaceuticalsL Piotroski F Score and Zentalis PharmaceuticalsL Altman Z Score analysis. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Zentalis Stock analysis
When running Zentalis PharmaceuticalsL's price analysis, check to measure Zentalis PharmaceuticalsL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zentalis PharmaceuticalsL is operating at the current time. Most of Zentalis PharmaceuticalsL's value examination focuses on studying past and present price action to predict the probability of Zentalis PharmaceuticalsL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zentalis PharmaceuticalsL's price. Additionally, you may evaluate how the addition of Zentalis PharmaceuticalsL to your portfolios can decrease your overall portfolio volatility.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
CEOs Directory Screen CEOs from public companies around the world | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is Zentalis PharmaceuticalsL's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis PharmaceuticalsL. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis PharmaceuticalsL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.47) | Return On Assets (0.29) | Return On Equity (0.67) |
The market value of Zentalis PharmaceuticalsL is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis PharmaceuticalsL's value that differs from its market value or its book value, called intrinsic value, which is Zentalis PharmaceuticalsL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis PharmaceuticalsL's market value can be influenced by many factors that don't directly affect Zentalis PharmaceuticalsL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis PharmaceuticalsL's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zentalis PharmaceuticalsL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis PharmaceuticalsL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.